Elevance Health (ELV) Cash & Current Investments (2009 - 2026)

Elevance Health (ELV) has reported Cash & Current Investments for 18 consecutive years, with $36.0 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash & Current Investments rose 278.67% year-over-year to $36.0 billion; the TTM figure through Jun 2026 stood at $36.0 billion (up 278.67% YoY), while the FY2025 annual figure was $10.2 billion, up 7.92% from the prior year.
• Cash & Current Investments rose to $36.0 billion in Q2 2026 per ELV's latest filing, from $35.6 billion in the prior quarter.
• Across five years, Cash & Current Investments topped out at $36.0 billion in Q2 2026 and bottomed at $6.7 billion in Q1 2024.
• Historically, Cash & Current Investments has averaged $13.3 billion across 5 years, with a median of $9.5 billion in 2024.
• Annual changes were most pronounced in 2022 — Cash & Current Investments slumped 76.91% — and 2026, when it surged 332.89%.
• Elevance Health's Cash & Current Investments stood at $8.3 billion in 2022, then retreated by 19.0% to $6.8 billion in 2023, then jumped by 40.34% to $9.5 billion in 2024, then grew by 7.92% to $10.2 billion in 2025, then surged by 251.39% to $36.0 billion in 2026.
• Business Quant data shows ELV's Cash & Current Investments at $36.0 billion in Q2 2026, $35.6 billion in Q1 2026, and $10.2 billion in Q4 2025.